Form 4 for NKTR NEKTAR THERAPEUTICS
Accepted 2021-08-31 00:00:00 ET · period of report 2021-08-31 · accession 0001209191-21-054136 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-31 | 2021-08-31 | NKTR | GREER R SCOTT | Dir | M - OptEx | $12.70 | +45.0K | 270.7K | +20% | +$571.5K |
| D | 2021-08-31 | 2021-08-31 | NKTR | GREER R SCOTT | Dir | M - OptEx | $0.00 | -45.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-31 | M | A | 45,000 | $12.70 | 270,674 | D | — | — | |
| 2 | Derivative | Stock Option | 2021-08-31 | M | D | 45,000 | $0.00 | 0 | D | $12.70 · 2015-09-30 to 2022-09-22 | 45,000 Common Stock |